{"id":1068251,"date":"2023-03-23T00:21:39","date_gmt":"2023-03-23T04:21:39","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/tempest-reports-year-end-2022-financial-results-and-provides-business-update\/"},"modified":"2024-08-18T11:44:57","modified_gmt":"2024-08-18T15:44:57","slug":"tempest-reports-year-end-2022-financial-results-and-provides-business-update","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/tempest-reports-year-end-2022-financial-results-and-provides-business-update.php","title":{"rendered":"Tempest Reports Year End 2022 Financial Results and Provides\u00a0Business Update"},"content":{"rendered":"<p><![CDATA[BRISBANE, Calif., March  22, 2023  (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-class1 therapeutics that combine both targeted and immune-mediated mechanisms, today reported financial results for the year ended December 31, 2022 and provided a corporate update.]]><\/p>\n<p>See the original post here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2023\/03\/22\/2632768\/0\/en\/Tempest-Reports-Year-End-2022-Financial-Results-and-Provides-Business-Update.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Tempest Reports Year End 2022 Financial Results and Provides\u00a0Business Update\">Tempest Reports Year End 2022 Financial Results and Provides\u00a0Business Update<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the original post here: Tempest Reports Year End 2022 Financial Results and Provides\u00a0Business Update <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/tempest-reports-year-end-2022-financial-results-and-provides-business-update.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068251","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068251"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068251"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068251\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}